Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP Trial

Study ID: NCT05920694
Start Date: 2022-12-22
End Date: 2025-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Continuous Positive Airway Pressure Device (CPAP)

Delayed Continuous Positive Airway Pressure Device (CPAP)

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

Study ID: NCT06431594
Start Date: 2024-07-02
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

240

Intervention / Treatment

Jokkhah, 4

Sponsor

GlaxoSmithKline

Source: clinicaltrials.gov

Share:
Add to list

Lurbinectedin in FET-Fused Tumors

Study ID: NCT05918640
Start Date: 2023-07-27
End Date: 2028-07-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

63

Intervention / Treatment

Lurbinectedin

Sponsor

Children's Hospital of Philadelphia

Source: clinicaltrials.gov

Share:
Add to list

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children with Generalized Myasthenia Gravis

Study ID: NCT04833894
Start Date: 2021-10-26
End Date: 2027-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

12

Intervention / Treatment

Efgartigimod IV

Sponsor

argenx

Source: clinicaltrials.gov

Share:
Add to list

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Study ID: NCT05000294
Start Date: 2021-12-07
End Date: 2026-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

29

Intervention / Treatment

Atezolizumab

Pucking

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

Study ID: NCT05422794
Start Date: 2023-05-18
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

57

Intervention / Treatment

Bet Bromodomain Inhibitor Zen-3694

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Nab-paclitaxel

Pembrolizumab

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma

Study ID: NCT06031194
Start Date: 2023-05-10
End Date: 2025-11-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Non-Interventional Study

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study

Study ID: NCT06535867
Start Date: 2024-07-30
End Date: 2031-07-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

5122

Intervention / Treatment

mHealth

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors

Study ID: NCT05984667
Start Date: 2023-09-15
End Date: 2026-09-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

72

Intervention / Treatment

C-SMART

Sponsor

Virginia Commonwealth University

Source: clinicaltrials.gov

Share:
Add to list

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Study ID: NCT06843967
Start Date: 2025-02-19
End Date: 2028-08-19
Study Type

Interventional

Study Phase

Phase2

No. of Participants

54

Intervention / Treatment

Mirdamet

Palbociclib

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list